Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Debt Ratio (2016 - 2025)

Heron Therapeutics (HRTX) has disclosed Debt Ratio for 5 consecutive years, with 0.42 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 292.85% year-over-year to 0.42, compared with a TTM value of 0.42 through Dec 2025, up 292.85%, and an annual FY2025 reading of 0.42, up 292.85% over the prior year.
  • Debt Ratio was 0.42 for Q4 2025 at Heron Therapeutics, down from 0.43 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.43 in Q3 2025 and bottomed at 0.1 in Q3 2023.
  • Average Debt Ratio over 3 years is 0.18, with a median of 0.11 recorded in 2024.
  • Peak annual rise in Debt Ratio hit 292.85% in 2025, while the deepest fall reached 4.68% in 2025.
  • Year by year, Debt Ratio stood at 0.11 in 2023, then dropped by 1.56% to 0.11 in 2024, then surged by 292.85% to 0.42 in 2025.
  • Business Quant data shows Debt Ratio for HRTX at 0.42 in Q4 2025, 0.43 in Q3 2025, and 0.11 in Q1 2025.